Group items tagged

For Fiscal Year 2015, the Advanced Energy Systems (AES) Program will solicit proposals under this Funding Opportunity Announcement for support of the Gasification Systems technology area. There will be a total of two Areas of Interest. The AES Program is pursuing research and development to (1) accelerate in-situ bio-gasification of coal seams with a goal of creating methane at a lower cost than typical U.S. natural gas recovery systems; and (2) produce oxygen for use in coal gasification processes at a significantly lower cost than that of the commercial state of the art technology.

We are pleased to announce that the new OARS website is up and running (although the new Research Compliance and Undergraduate Research sections are still in development).   If you haven't had a chance to check it out yet, we hope you will soon.  Once you've visited, we'd be grateful if you'd give us five minutes of your time to let us know how we're doing by completing a brief eight-question survey at https://miamioh.qualtrics.com/SE/?SID=SV_erhRsEFwwWVP6m1 Finally, don't forget to update any bookmarks you may have to material on our old website!

DARPA is soliciting innovative research proposals in the field of UV laser technology that will enable enhanced detection and discrimination of specific biological and chemical compounds using Raman spectroscopy. The goal of the Laser UV Sources for Tactical Efficient Raman (LUSTER) program is to develop compact, efficient, high-power ultraviolet lasers capable of achieving output power >1 W, wall-plug efficiency >10%, linewidth < 0.01 nm and all at wavelengths between 220-240 nm. Various methods such as direct electrical injection, electron beam pumping, second harmonic generation or other alternatives will be considered as long as all of the metrics can be met or exceeded. See the full DARPA-BAA-14-20 document attached.

The NIH encourages institutions that seek to engage undergraduate students in innovative mentored research training programs to submit applications for cooperative agreement awards through the NIH Building Infrastructure Leading to Diversity (BUILD) initiative, one of three new Common Fund initiatives that together aim to enhance diversity in the biomedical, behavioral, clinical, and social sciences research workforce. Addressing a major leakage point in the research workforce pipeline, BUILD awards are intended to support the design and implementation of innovative programs, strategies and approaches to transform undergraduate research training and mentorship. BUILD awards will also support institutional and faculty development to further strengthen undergraduate research training environments.

The Experimental Program to Stimulate Competitive Research (EPSCoR) is a program designed to fulfill the National Science Foundation's (NSF) mandate to promote scientific progress nationwide. The EPSCoR program is directed at jurisdictions that have historically received lesser amounts of NSF Research and Development (R&D) funding. Thirty-one jurisdictions including twenty-eight states, the Commonwealth of Puerto Rico, the U. S. Virgin Islands, and Guam currently are eligible to participate. Through this program, NSF establishes partnerships with government, higher education, and industry that are designed to effect lasting improvements in a state's or region's research infrastructure, R&D capacity and hence, its national R&D competitiveness.Research Infrastructure Improvement Program: Track-2 (RII Track-2) awards provide funds in the range of $1.5 to 2.0 million per year for up to 3 years to consortia of EPSCoR jurisdictions. The awards promote opportunities for collaborations among EPSCoR jurisdictions in all areas of science, engineering, and education supported by the National Science Foundation (NSF). RII Track-2 proposals must describe a clear, comprehensive, and integrated vision to drive discovery, and train a skilled workforce capable of solving science and engineering challenges of regional, thematic, and national relevance. Proposals should also include a strong rationale for the establishment of the consortium and clearly demonstrate that the consortium is well-positioned to produce results that cannot be obtained by any single partner working independently. The Science, Technology, Engineering, and Mathematics (STEM) research and education activities should broaden participation by different types of institutions, individuals, and sectors in the project.

The Division of Molecular and Cellular Biosciences (MCB) supports quantitative, predictive, and theory-driven fundamental research and related activities designed to promote understanding of complex living systems at the molecular, subcellular, and cellular levels. MCB is soliciting proposals for hypothesis-driven and discovery research and related activities in four core clusters: Molecular Biophysics Cellular Dynamics and Function Genetic Mechanisms Systems and Synthetic Biology MCB gives high priority to research projects that use theory, methods, and technologies from physical sciences, mathematics, computational sciences, and engineering to address major biological questions.  Research supported by MCB uses a range of experimental approaches--including in vivo, in vitro and in silico strategies--and a broad spectrum of model and non-model organisms, especially microbes and plants. Typical research supported by MCB integrates theory and experimentation.  Projects that address the emerging areas of multi-scale integration, molecular and cellular evolution, quantitative prediction of phenome from genomic information, and development of methods and resources are particularly welcome.

The Centers of Research Excellence in Science and Technology (CREST) program provides support to enhance the research capabilities of minority-serving institutions (MSI) through the establishment of centers that effectively integrate education and research. CREST promotes the development of new knowledge, enhancements of the research productivity of individual faculty, and an expanded presence of students historically underrepresented in science, technology, engineering, and  mathematics (STEM) disciplines. HBCU-RISE awards specifically target HBCUs to support the expansion of institutional research capacity as well as the production of doctoral students, especially those from groups underrepresented in STEM,  at those institutions.

This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements will improve the detection of antibiotic resistance among enteric bacteria in food commodities, as well as potentially develop new sites as part of the program. Measurable outcomes of the program will be in alignment with the NARMS Objectives.

Cell-based therapies, especially immune cells, have the potential to revolutionize human healthcare in various different contexts, including cancer and personalized medicine. For example, CAR (Chimeric antigen receptor) T-cell therapy for cancer requires modification, in vitro culture and expansion of human T-cells.   Manufacturing of therapeutic cells as the end product presents major engineering challenges.  New therapies and cell-based products depend critically on the development of robust, reliable and reproducible biomanufacturing technologies.

This funding opportunity announcement (FOA) seeks applications from institutions/organizations for a cooperative agreement research grant (UM1) to conduct a clinical trial across three or more Low and Middle Income Country (LMIC) settings to test improved stove and fuel interventions on health outcomes in exposed populations. In addition, each application must include a biomarker center element for the development and validation of clinical, physiological, chemical, biochemical and/or microbiological markers of: a) exposure, and b) pathophysiological responses.

The Elsevier Green and Sustainable Chemistry Challenge is open to individuals or organisations operating in the not-for-profit and for-profit sectors from all countries. Projects can be in any field of Green or Sustainable Chemistry so long as they are applicable for use in developing countries. Projects which are within their early stage are preferred. The winning project in the Elsevier Green and Sustainable Chemistry Challenge will receive a single payment of € 50,000; the winner of the second prize will receive a single payment of € 25,000.

The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from public nonprofit institutions/organizations (includes institutions of higher education and hospitals) to perform research and analysis of data to inform drug policy. This project seeks to further refine a methodology for obtaining drug early warning indicators from expanded testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations - including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. 

The purpose of this funding opportunity is to support the research and development necessary to advance spectroscopic imaging technologies, methods, study designs, and analyses to non-invasively measure the rate and extent to which a topically applied compound becomes available in the epidermis, at or near a site of action within the skin. The expectation is that the funded work will produce an accurate, sensitive and reproducible approach that measures the amount of drug present in the epidermis at each of a series of depths below the skin surface, which can be utilized to monitor epidermal pharmacokinetics by repeated measurements over time.

NineSigma, representing a major material manufacturer, seeks partners to develop a switchable dimming film that changes from a natural black (dark gray) color to transparency. We particularly expect technologies that enable the active modulation of black color and transparency. An elemental technology or film formation technology are also welcomed.

NineSigma, representing Wärtsilä Moss, seeks innovative technologies that can remove water vapor from a continuous air flow. Technologies based on new principles, even at a research stage, are especially welcomed. Wärtsilä provides environmentally and economically sound integrated solutions for various merchant vessels including LNG carriers. When LNG tanks are emptied they have to be aerated to remove all combustible gases. These tanks are however very cold (-40°C) and any vapor in the air will freeze inside the tank. The current air dehumidification method Wärtsilä Moss installs on LNG carriers is based on chillers that cool the air down to 5°C to remove most of the water vapor, followed by passing the air through a desiccant tower packed with activated alumina. Although this approach is effective it is not easy to scale and the installed capacity is not always used in an optimal way. Thus, the client seeks novel techniques which are being developed to dehumidify air or an inert gas like N2.

The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from three or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations, or to 2) significantly expand the scientific scope of existing collaborations, or to 3) engage new collaborators in pre-existing collaborations to address the purpose of this FOA

The Chan Zuckerberg Initiative (CZI) seeks to support up to 10 Imaging Scientists who will work at the interface of biology, microscopy hardware, and imaging software at imaging centers across the United States. "Imaging Scientists" might be engineers, physicists, mathematicians, computer scientists, or biologists who have focused on technology development in either microscopy or data analysis fields. The primary goal of the program is to increase interactions between biologists and technology experts. The Imaging Scientists will have expertise in microscopy hardware and/or imaging software. A successful "Imaging Program" will employ an Imaging Scientist who: a) works collaboratively with experimental biologists on projects at the imaging center; b) participates in courses that disseminate advanced microscopy methods and analysis; c) trains students and postdocs in imaging technology; d) participates in a network of CZI Imaging Scientists to identify needs and drive advances in the imaging field; e) attends twice-yearly CZI scientific workshops and meetings in imaging and adjacent biomedical areas. Each grant will fund salary and fringe benefits for an Imaging Scientist at the center, a modest travel and teaching budget, plus 15% indirect costs. The award period is three years plus an additional two years if the Imaging Program passes a review at year three.

The DARPA Microsystems Technology Office is soliciting research proposals for the development of a new class of atom-based systems utilizing integrated photonics and trapped atoms to enable high-performance, robust, portable clocks and gyroscopes.

NineSigma, representing a Japanese leading pharmaceutical company, seeks drug discovery projects which make use of any of the following drug discovery underlying technologies and which are in a hit discovery stage. It is preferable that the research has already started; however, proposals are welcome also from an organization with plans to start a specific project in the future. The client aims to build a drug discovery platform, which is globally competitive, through collaboration with partners. The client can provide opportunities, depending on the R&D stage and the business plan of partners, and hopes not only to foster joint research and development, but also to maximize outcome creation by licensing, support with budget, etc. to support improvement of underlying technology.

Through the #2018AirLiquideScientificChallenge, Air Liquide embarks the scientific community to innovate using Essential Small Molecules and develop new applications on 3 topics related to improving air quality for the people and fighting climate change for the planet. Be part of the Air Liquide's innovative approach (inventiveness, curiosity, collective intelligence, and agility) by participating in the challenge.